RecruitingNot ApplicableNCT07527208

The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial


Sponsor

Cornell University

Enrollment

28 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

During fasting, the body shifts from using carbohydrates to relying more on fat as its main source of energy. This process is known as the 'metabolic shift'. Fat tissue helps supply this energy by breaking down stored fat into fatty acids, which are released into the bloodstream and transported to organs throughout the body. In addition to fatty acids, many other substances in the blood (such as metabolites) change during fasting to help maintain normal body function. Immune cells also circulate in the blood and play an important role in protecting the body against infections and diseases such as cancer. However, it is not yet well understood how the metabolic shift during fasting affects immune cell function. The purpose of this study is to investigate how 24 hours of fasting influences immune cell metabolism and function.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria5

  • Apparently healthy
  • Age 18-40y at the time of recruitment
  • BMI ≥ 18.5 and ≤ 24.9 kg/m2
  • Willing to participate in all study activities during the 3-day intervention
  • Signed informed consent

Exclusion Criteria16

  • Diagnosed with any chronic medical condition that can interfere with the study outcome (e.g., cardiovascular disease, cancer, diabetes mellitus type 1 or 2, liver disease, pulmonary disease, renal disease, inflammatory bowel disease, thyroid disease, long COVID, PASC)
  • Bleeding disorder (e.g., Hemophilia A/B, Von Willebrand Disease, or low platelets), current anemia or current use of blood thinners or anticoagulants (e.g. warfarin, heparin)
  • Any acute or chronic infection disease or fever in the past month
  • Antibiotic use in the past 2 months
  • Use of any prescribed medications (incl. GLP-1 agonists), except for contraceptives
  • Usage of recreational drugs in the last three months
  • Unstable body weight (weight gain or loss >5% of total BW in the past three months)
  • Following any restrictive diet within one month of starting the study (for example a ketogenic diet or weight loss diet)
  • Fasted for 16 hours or longer in the past week
  • History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating disorder)
  • Allergic to one or more components of the standardized meal and/or shake (i.e., milk, wheat, and soy)
  • Average alcohol intake that exceeds 1 consumption/day or 7 consumptions/week over the past month
  • Tobacco smoker or regular use of nicotine products
  • Donated or intend to donate blood from 2 months before the study until the end of the study
  • Being pregnant or lactating
  • Participation in another biomedical study during this study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFasting

After consumption of a standardized breakfast (energy content adjusted to individual BMR), participants will undergo a 26-hour fast (water only), followed by consumption of a second standardized breakfast.


Locations(1)

Human Metabolic Research Unit, Division of Nutritional Sciences. Cornell University

Ithaca, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07527208


Related Trials